Effects of methysergide on platelets incubated with reserpine.
1. Platelets were incubated with methysergide and related compounds (2-bromo lysergic acid (BOL), ergotamine and methyl ergotamine) together with reserpine.2. Methysergide inhibited the normal aggregation response of platelets to 5-hydroxytryptamine (5HT) but did not affect the reduction in the 5HT content caused by reserpine, or the uptake of 5HT by the platelets.3. BOL, ergotamine and methyl ergotamine behaved similarly. Methysergide had greater anti5HT potency than BOL, and methyl ergotamine had greater potency than ergotamine.4. The use of platelets as a model for synaptic preparations is discussed.5. The role of 5HT receptor sites on the platelet membrane and the significance of the results for migraine patients treated with methysergide are discussed.
D001792:Blood Platelets / Q000187:drug effects*; D001966:Bromine / Q000494:pharmacology; D004873:Ergolines / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008784:Methysergide / Q000494:pharmacology* / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy; D012110:Reserpine / Q000494:pharmacology*; D012702:Serotonin Antagonists
D004873:Ergolines; D012702:Serotonin Antagonists; D012110:Reserpine; D004878:Ergotamine; D001966:Bromine; D008784:Methysergide